119 related articles for article (PubMed ID: 12070711)
1. Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression.
Wu S; Murrell GA; Wang Y
Cancer Immunol Immunother; 2002 Jul; 51(5):248-54. PubMed ID: 12070711
[TBL] [Abstract][Full Text] [Related]
2. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes.
Sitrin RG; Todd RF; Mizukami IF; Gross TJ; Shollenberger SB; Gyetko MR
Blood; 1994 Aug; 84(4):1268-75. PubMed ID: 8049441
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells.
Sirén V; Myöhänen H; Vaheri A; Immonen I
Ophthalmic Res; 1999; 31(3):184-91. PubMed ID: 10224501
[TBL] [Abstract][Full Text] [Related]
5. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Shetty S; Kumar A; Idell S
Mol Cell Biol; 1997 Mar; 17(3):1075-83. PubMed ID: 9032234
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
Montuori N; Mattiello A; Mancini A; Santoli M; Taglialatela P; Caputi M; Rossi G; Ragno P
FEBS Lett; 2001 Nov; 508(3):379-84. PubMed ID: 11728456
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
8. Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton.
Bayraktutan U; Jones P
Exp Cell Res; 1995 Dec; 221(2):486-95. PubMed ID: 7493649
[TBL] [Abstract][Full Text] [Related]
9. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells.
Wang Y; Jones CJ; Dang J; Liang X; Olsen JE; Doe WF
FEBS Lett; 1994 Oct; 353(2):138-42. PubMed ID: 7926038
[TBL] [Abstract][Full Text] [Related]
10. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937.
Peiretti F; Fossat C; Anfosso F; Alessi MC; Henry M; Juhan-Vague I; Nalbone G
Blood; 1996 Jan; 87(1):162-73. PubMed ID: 8547638
[TBL] [Abstract][Full Text] [Related]
11. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
Antalis TM; Reeder JA
Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
[TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
Huang S; New L; Pan Z; Han J; Nemerow GR
J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
[TBL] [Abstract][Full Text] [Related]
13. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
Nip J; Rabbani SA; Shibata HR; Brodt P
J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
Dang J; Wang Y; Doe WF
FEBS Lett; 1995 Feb; 359(2-3):147-50. PubMed ID: 7867787
[TBL] [Abstract][Full Text] [Related]
15. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
Wang Y; Dang J; Liang X; Doe WF
Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
[TBL] [Abstract][Full Text] [Related]
16. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
Mazumdar A; Adam L; Boyd D; Kumar R
Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
[TBL] [Abstract][Full Text] [Related]
17. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
18. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
19. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
[TBL] [Abstract][Full Text] [Related]
20. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
Iwamoto J; Takahashi K; Mizokami Y; Otsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokoube K; Matsuoka T
Dig Dis Sci; 2003 Dec; 48(12):2247-56. PubMed ID: 14714609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
